. Author manuscript; available in PMC: 2014 Jul 1.

Published in final edited form as: Prog Neuropsychopharmacol Biol Psychiatry. 2013 Feb 4;44:131–135. doi: 10.1016/j.pnpbp.2013.01.020

Table 1.

Patients and healthy control subjects: baseline demographic and clinical information.

	Age (mean yr ± SD)	Mean ± SD VAS anxiety level (0–100 mm)	Mean ± SD Panic Disorder Severity Scale (PDSS)	Mean ± SD Trails Making Test Part B (TMT-B) test score
Patients (PDP, n = 11)	38.2 ± 12.7	45.8 ± 28.8^**	9.8 ± 3.3^**	10.3 ± 2.6
Patients with PD family history (Pw/F, n = 5)	32.6 ± 5.9	38.2 ± 36.8^*	10.6 ± 4.7^**	10.8 ± 3.8
Patients without PD family history (Pw/oF, n = 6)	42.8 ± 15.5	52.2 ± 21.6^**	9.2 ± 1.8^**	9.3 ± 1.0
Controls (n = 8)	39.5 ± 12.1	4.1 ± 8.0	0	12.3 ± 3.7

p<0.05 compared to controls.

^**

p<0.01 compared to controls.